BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/26/2025 4:06:58 AM | Browse: 230 | Download: 661
Publication Name World Journal of Hepatology
Manuscript ID 103835
Country United States
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Letter to the Editor
Article Title Role of autoimmune phenomena in nonalcoholic fatty liver disease: Insights and limitations
Manuscript Source Invited Manuscript
All Author List Arunkumar Krishnan and Diptasree Mukherjee
ORCID
Author(s) ORCID Number
Arunkumar Krishnan http://orcid.org/0000-0002-9452-7377
Diptasree Mukherjee http://orcid.org/0000-0002-8962-2759
Funding Agency and Grant Number
Corresponding Author Arunkumar Krishnan, Assistant Professor, MD, Department of Supportive Oncology, Atrium Health Levine Cancer, 1021 Morehead Medical Drive, Suite 70100, Charlotte, NC 28204, United States. dr.arunkumar.krishnan@gmail.com
Key Words Nonalcoholic fatty liver disease; Metabolic dysfunction-associated steatotic liver disease; Liver; Regression; Liver pathology; Autoantibody; Autoimmune
Core Tip A study by Zhu et al investigated the presence of autoantibodies across different histological stages of nonalcoholic fatty liver disease (NAFLD). The findings suggest that autoantibodies may play a role in the immune dysregulation observed in NAFLD. We recommend further refinement by incorporating prospective methods and controlling for additional confounding factors such as body mass index and metabolic comorbidities. Expanding the antibody panel and measuring antibody titers with greater granularity could enhance the accuracy. Moreover, stratifying data by age and sex and exploring cytokine profiles may provide a better understanding of the immunological mechanisms involved in NAFLD progression.
Publish Date 2025-03-26 04:06
Citation

Krishnan A, Mukherjee D. Role of autoimmune phenomena in nonalcoholic fatty liver disease: Insights and limitations. World J Hepatol 2025; 17(3): 103835

URL https://www.wjgnet.com/1948-5182/full/v17/i3/103835.htm
DOI https://dx.doi.org/10.4254/wjh.v17.i3.103835
Full Article (PDF) WJH-17-103835-with-cover.pdf